What bloodwork or testing is important for a pre-operative evaluation in a patient with a history of central retinal artery (CRA) occlusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with a history of distant retinal artery blood clot, a comprehensive preoperative evaluation should include a thorough thrombophilia workup and cardiovascular assessment to minimize the risk of perioperative thrombotic events and bleeding complications. This approach is based on the most recent guidelines and evidence, including the 2021 scientific statement from the American Heart Association on the management of central retinal artery occlusion 1. The evaluation should consist of:

  • Complete blood count
  • Coagulation studies (PT, PTT, INR)
  • Lipid panel
  • Fasting blood glucose
  • Hemoglobin A1c
  • Inflammatory markers like ESR and CRP
  • Additional testing for homocysteine levels, protein C and S activity, antithrombin III levels, factor V Leiden mutation, prothrombin gene mutation, antiphospholipid antibodies, and lupus anticoagulant
  • Cardiovascular evaluation with an ECG, echocardiogram, and carotid ultrasound to identify potential embolic sources The initial evaluation of patients with transient retinal or hemispheric neurological symptoms of possible ischemic origin should include noninvasive imaging for the detection of extracranial carotid and vertebral artery disease, as recommended by the 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline 1. Medication management is crucial, particularly for patients on anticoagulants like warfarin, aspirin, or clopidogrel, and consultation with both ophthalmology and cardiology is recommended to balance the risk of perioperative thrombotic events against bleeding complications 1. The goal of this comprehensive approach is to minimize the risk of morbidity, mortality, and long-term disability, and to improve the patient's quality of life.

From the Research

Pre-Operative Evaluation for Patients with a History of Distant Retinal Artery Blood Clot

The following bloodwork and testing are important for a pre-operative evaluation:

  • Thrombophilia measures:
    • Factor V Leiden 2
    • Prothrombin 2
    • C677T MTHFR 2
    • Platelet glycoprotein PlA1/A2 2
  • Serologic thrombophilia measures:
    • Protein C 2, 3
    • Protein S (total and free) 2
    • Antithrombin III 2, 3
    • Homocysteine 2, 3
    • Lupus anticoagulant 2
    • Anticardiolipin antibodies IgG-IgM 2
    • Factors VIII and XI 2
  • Serologic hypofibrinolysis measures:
    • Lp(a) 2
    • Plasminogen activator inhibitor activity 2
    • Plasminogen activator inhibitor-1 4G4G 2
  • Coagulation tests:
    • Prothrombin fragment 1+2 (F1+2) 3
    • Thrombin-antithrombin III complex (TAT) 3
    • D-dimer 3 These tests can help identify potential thrombophilic or hypofibrinolytic conditions that may increase the risk of another retinal artery blood clot or other thrombotic events during surgery 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2008

Research

Blood coagulation parameters in retinal arterial occlusion.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.